To view this email as a web page, click here.
Conference Coverage
 
 October 20, 2018
 
The annual Fall Clinical Dermatology Conference is taking place this week in Las Vegas. Visit our conference page for our news reports from the meeting.
 
Treatment options for benign lesions
Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.
 
Considerations for selecting laser technology
There are plenty of laser technologies for the practice, but then there are cornerstone lasers every practice should have. Learn more in this article from the Fall Clinical conference.
 
The two faces of botulinum toxin
While botulinum toxin is most commonly used to relieve frowns and wrinkles, it is increasingly being shown to be associated with improving mood and relationships, a researcher says.
 
Topical therapy uses in psoriasis and atopic dermatitis
Reporting from Fall Clinical in Las Vegas, Dr. James Del Rosso reviews best practices for topical therapy uses in psoriasis and atopic dermatitis.
 
Four effective anti-IL 23 drugs for psoriasis
Two approved and two pending anti-IL 23 drugs offer an opportunity for moderate to severe psoriasis patients to regain their lives, according to researchers presenting at the 2018 Fall Clinical Dermatology Conference.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.